Carevive Acquired by Health Catalyst
Health Catalyst United States
BOSTON, June 18, 2024 – Bowen is pleased to announce that Carevive Systems, a market-leading technology innovator for value-based cancer care, has been acquired by Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Bowen acted as the exclusive M&A advisor to Carevive.
Carevive is a pioneer in using software and data to improve oncology care. Carevive’s product suite encompasses care planning, workflow and patient-reported health data to improve patient outcomes, lower the costs of cancer care, and enhance clinical research. The Company’s SaaS platform empowers oncology practices to monitor and manage patients remotely, enabling improved symptom management and more personalized treatments. As Carevive touches nearly every aspect of cancer care, it provides a rich data offering used by providers and other key stakeholders, such as pharmaceutical companies, to improve drug selection and tolerability and advance drug development.
“As healthcare shifts toward value-based models, there is a growing need for innovative solutions that prioritize patient-centric care and improve outcomes,” said Bob Fleming, Managing Director at Bowen. “Carevive’s industry-leading platform will play a pivotal role in shaping the future of oncology care. Health Catalyst is an exceptional partner for the next phase of Carevive’s growth.”
Bowen’s healthcare team brings extensive industry expertise and a proven track record in advising companies like Carevive on strategic transactions. “This is the second time Carevive has partnered with Bowen on a successful process. They have built a strong relationship with our team, and their support was essential in managing all stakeholders and successfully closing the deal,” said Allen Kamer, Executive Chairman.
Read more:
